Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NX-1207
NX-1207
Nymox Drug for Enlarged Prostate Doesn’t Meet Targets
Bloomberg
Mon, 11/3/14 - 08:04 am
Nymox
enlarged prostate
NX-1207
Incorrect biopsy results cloud Nymox Pharma prostate cancer study
Yahoo/Reuters
Wed, 04/30/14 - 10:21 am
Nymox
prostate cancer
NX-1207
Nymox Pharmaceutical (NYMX +3.2%) is set to close in the green today after the company provided a positive update on Phase 2 clinical trials for NX-1207
Seeking Alpha
Wed, 03/6/13 - 10:48 am
NX-1207
prostate cancer
Nymox
Pipeline Progresses at Nymox
Yahoo/Zacks
Fri, 07/13/12 - 12:24 pm
Nymox
benign prostatic hyperplasia
BPH
NX-1207
Nymox Pharmaceutical Corporation : Nymox Announces Positive Safety Monitoring Committee Results for Phase 3 NX-1207 Trials for BPH
4-Traders
Sat, 04/28/12 - 12:57 pm
Nymox
NX-1207
benign prostatic hyperplasia
BPH
Nymox: Another Look at Enlarged-Prostate Drug
TheStreet.com
Thu, 02/10/11 - 10:52 am
Nymox
enlarged prostate
NX-1207